These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22332939)

  • 1. Serum ferritin and total units transfused for assessing iron overload in adults with sickle cell disease.
    Drasar E; Vasavda N; Igbineweka N; Awogbade M; Allman M; Thein SL
    Br J Haematol; 2012 Jun; 157(5):645-7. PubMed ID: 22332939
    [No Abstract]   [Full Text] [Related]  

  • 2. Gaps in the diagnosis and management of iron overload in sickle cell disease: a 'real-world' report from the GRNDaD registry.
    Wilson SR; Sears M; Williams E; Drapekin J; Sivakumar I; Padrino S; Desai PC; Hager W; Manwani D; Clay LJ; Field JJ; Kanter J; Cohen AJ; Saif Ur Rehman S; Lanzkron S; Little JA;
    Br J Haematol; 2021 Dec; 195(5):e157-e160. PubMed ID: 34423416
    [No Abstract]   [Full Text] [Related]  

  • 3. Iron overload is a determinant of morbidity and mortality in adult patients with sickle cell disease.
    Ballas SK
    Semin Hematol; 2001 Jan; 38(1 Suppl 1):30-6. PubMed ID: 11206959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal MRI and Ferritin Monitoring of Iron Overload in Chronically Transfused and Chelated Children With Sickle Cell Anemia and Thalassemia Major.
    Aubart M; Ou P; Elie C; Canniffe C; Kutty S; Delos V; Graffigne C; de Montalembert M; Brousse V
    J Pediatr Hematol Oncol; 2016 Oct; 38(7):497-502. PubMed ID: 27548334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron overload in adults with sickle cell disease who have received intermittent red blood cell transfusions.
    Pack-Mabien A; Brown B; Herbert DE; Haynes J
    J Am Assoc Nurse Pract; 2015 Oct; 27(10):591-6. PubMed ID: 25711464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy.
    Harmatz P; Butensky E; Quirolo K; Williams R; Ferrell L; Moyer T; Golden D; Neumayr L; Vichinsky E
    Blood; 2000 Jul; 96(1):76-9. PubMed ID: 10891433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron overload indices rise linearly with transfusion rate in patients with sickle cell disease.
    Inati A; Musallam KM; Wood JC; Taher AT
    Blood; 2010 Apr; 115(14):2980-1; author reply 2981-2. PubMed ID: 20378761
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of serial serum ferritin measurements and liver iron concentration assessed by MRI in adult transfused patients with sickle cell disease.
    Tsitsikas DA; Nzouakou R; Ameen V; Sirigireddy B; Amos RJ
    Eur J Haematol; 2014 Feb; 92(2):164-7. PubMed ID: 24175986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing cardiac and liver iron overload in chronically transfused patients with sickle cell disease.
    Badawy SM; Liem RI; Rigsby CK; Labotka RJ; DeFreitas RA; Thompson AA
    Br J Haematol; 2016 Nov; 175(4):705-713. PubMed ID: 27507431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth differentiation factor-15 in young sickle cell disease patients: relation to hemolysis, iron overload and vascular complications.
    Tantawy AA; Adly AA; Ismail EA; Darwish YW; Ali Zedan M
    Blood Cells Mol Dis; 2014 Dec; 53(4):189-93. PubMed ID: 25065856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced vitamin E antioxidant capacity in sickle cell disease is related to transfusion status but not to sickle crisis.
    Marwah SS; Blann AD; Rea C; Phillips JD; Wright J; Bareford D
    Am J Hematol; 2002 Feb; 69(2):144-6. PubMed ID: 11835354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consequences and management of iron overload in sickle cell disease.
    Porter J; Garbowski M
    Hematology Am Soc Hematol Educ Program; 2013; 2013():447-56. PubMed ID: 24319218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferritin trends do not predict changes in total body iron in patients with transfusional iron overload.
    Puliyel M; Sposto R; Berdoukas VA; Hofstra TC; Nord A; Carson S; Wood J; Coates TD
    Am J Hematol; 2014 Apr; 89(4):391-4. PubMed ID: 24347294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of iron overload on oxidative stress in sickle cell anemia.
    Dos Santos TE; de Sousa GF; Barbosa MC; Gonçalves RP
    Biomark Med; 2012 Dec; 6(6):813-9. PubMed ID: 23227847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid Function in Egyptian Children with Sickle Cell Anemia in Correlation with Iron Load.
    Hagag AA; El-Asy HM; Badraia IM; Hablas NM; El-Latif AEA
    Endocr Metab Immune Disord Drug Targets; 2019; 19(1):46-52. PubMed ID: 30207251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury.
    Adamkiewicz TV; Abboud MR; Paley C; Olivieri N; Kirby-Allen M; Vichinsky E; Casella JF; Alvarez OA; Barredo JC; Lee MT; Iyer RV; Kutlar A; McKie KM; McKie V; Odo N; Gee B; Kwiatkowski JL; Woods GM; Coates T; Wang W; Adams RJ
    Blood; 2009 Nov; 114(21):4632-8. PubMed ID: 19721013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease.
    Voskaridou E; Douskou M; Terpos E; Papassotiriou I; Stamoulakatou A; Ourailidis A; Loutradi A; Loukopoulos D
    Br J Haematol; 2004 Sep; 126(5):736-42. PubMed ID: 15327528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
    Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C
    Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal changes in ferritin during chronic transfusion: a report from the Stroke Prevention Trial in Sickle Cell Anemia (STOP).
    Files B; Brambilla D; Kutlar A; Miller S; Vichinsky E; Wang W; Granger S; Adams RJ
    J Pediatr Hematol Oncol; 2002 May; 24(4):284-90. PubMed ID: 11972097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approaches to transfusion therapy and iron overload in patients with sickle cell disease: results of an international survey.
    Vichinsky EP; Ohene-Frempong K;
    Pediatr Hematol Oncol; 2011 Feb; 28(1):37-42. PubMed ID: 20673029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.